Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis
By E. Bujold, S. Roberge, Y. Lacasse, M. Bureau, F. Audibert, S. Marcoux, J. Forest, Y. Giguère. Obstetrics and Gynecology, 2010
1,057 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Obstetrics and Gynecology
View Paper: https://www.semanticscholar.org/paper/4b93b5c475ac0a47b1136b894e94912b03ede86a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. (2018, background): “43 setting of low calcium intake) are recommended for the prevention of preeclampsia(62-64).”
- The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. (2021, background): “Women who book late for antenatal care may still benefit from aspirin started after 16 weeks, although the reduction in pre-eclampsia has been estimated to be non-significant [109].”
- ESH / ESC Guidelines for the management of arterial hypertension (2013, background): “09) compared with control.(505) Faced with these discrepant data, only prudent advice can be offered: women at high risk of pre-eclampsia (from hypertension in a previous preg-”
- The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta‐analysis (2017, positive): “Therefore, these authors performed a systematic review and meta-analyses of randomized controlled trials and evaluated the dose-response effect of aspirin on the prevention of PE and FGR. PE was defined as systolic blood pressure Z140mm Hg or diastolic blood pressure Z90mm Hg occurring after 20 week”